OneVentures • 03 September 2012

Hatchtech announce successful End-of-Phase 2 for head lice product DeOvo™

OneVentures

Learn More

You may also like

02 August 2020

Healthcare

FDA Approves Xeglyze™ for the topical treatment of head lice infestation


02 August 2020

Healthcare

Hatchtech gets lice treatment nod from FDA


01 February 2018

OneVentures

No nit picking: Head lice group Hatchtech gets green light to trials


21 October 2014

OneVentures

Hatchtech announces successful results from Phase 2 ovicidal study


View All